SCHEMBL27631682

SCHEMBL27631682

Nc1nc(N)c(-c2ccccc2)c(-c2cccc(O)c2)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.61
ADORA2A P29274 2/20 0.61
ADORA2B P29275 1/20 0.61
PIK3CG P48736 5/20 0.58
PIK3CA P42336 2/20 0.58
PIK3CB P42338 2/20 0.58
PIK3CD O00329 1/20 0.58
PIK3C2B O00750 1/20 0.58
PDXK O00764 1/20 0.58
GAK O14976 1/20 0.58
MAP3K7 O43318 1/20 0.58
RIPK2 O43353 1/20 0.58
PIP5K1C O60331 1/20 0.58
STK16 O75716 1/20 0.58
PIK3C2G O75747 1/20 0.58
PRKD3 O94806 1/20 0.58
OXSR1 O95747 1/20 0.58
LATS1 O95835 1/20 0.58
ABL1 P00519 1/20 0.58
EGFR P00533 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612333 0.94 ADORA1 (0.61) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL12137707 0.85 HEXA (0.57) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL12137855 0.85 DHFR (0.56) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL27631513 0.83 PIK3CG (0.59) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL2473930 0.83 DHFR (0.58) ADORA1ADORA2AADORA2BPIK3CGMTOR
SCHEMBL12138076 0.82 PIK3CG (0.50) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL12138067 0.82 CYP1A2 (0.56) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL12137467 0.82 ADORA1 (0.59) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
SCHEMBL12137684 0.81 PIK3CG (0.52) ADORA1ADORA2AADORA2BPIK3CGPIK3CA
Hydrochloric Acid SCHEMBL15487768 0.81 DHFR (0.56) ADORA1ADORA2AADORA2BPIK3CGMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed